← Back to Search

Breast MRI Imaging Techniques for Breast Cancer

N/A
Waitlist Available
Led By A. Bapsi Chakravarthy, MD
Research Sponsored by Vanderbilt-Ingram Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subjects with known or suspected breast disease
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 6 months
Awards & highlights

Study Summary

This trial is studying how well breast MRI works in diagnosing and predicting treatment response in women with breast cancer or those at high risk for the disease.

Eligible Conditions
  • Breast Cancer

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You have a known or suspected breast condition.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~on-study date and at 6 months, up to 4 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and on-study date and at 6 months, up to 4 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility of advanced, quantitative, multi-parametric magnetic resonance imaging (MRI) methods for characterizing breast tumors to develop potential surrogate imaging markers for diagnosis and prediction of treatment response
Secondary outcome measures
Correlation of biochemical data obtained from magnetic resonance analysis with clinical, radiological, and pathological findings
Establishment of an imaging data bank

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Participants with breast cancerExperimental Treatment3 Interventions
Group II: Participants without breast cancerActive Control3 Interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
dynamic contrast-enhanced magnetic resonance imaging
2006
Completed Phase 2
~450
magnetic resonance spectroscopic imaging
2010
N/A
~230
diffusion-weighted magnetic resonance imaging
2013
Completed Phase 1
~730

Find a Location

Who is running the clinical trial?

Vanderbilt-Ingram Cancer CenterLead Sponsor
213 Previous Clinical Trials
60,724 Total Patients Enrolled
27 Trials studying Breast Cancer
6,385 Patients Enrolled for Breast Cancer
National Cancer Institute (NCI)NIH
13,609 Previous Clinical Trials
40,915,437 Total Patients Enrolled
938 Trials studying Breast Cancer
1,543,124 Patients Enrolled for Breast Cancer
A. Bapsi Chakravarthy, MDPrincipal InvestigatorVanderbilt-Ingram Cancer Center
11 Previous Clinical Trials
4,340 Total Patients Enrolled
7 Trials studying Breast Cancer
4,203 Patients Enrolled for Breast Cancer

Media Library

dynamic contrast-enhanced magnetic resonance imaging Clinical Trial Eligibility Overview. Trial Name: NCT00474604 — N/A
Breast Cancer Research Study Groups: Participants with breast cancer, Participants without breast cancer
Breast Cancer Clinical Trial 2023: dynamic contrast-enhanced magnetic resonance imaging Highlights & Side Effects. Trial Name: NCT00474604 — N/A
dynamic contrast-enhanced magnetic resonance imaging 2023 Treatment Timeline for Medical Study. Trial Name: NCT00474604 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research program presently open for enrollment?

"According to information located on clinicaltrials.gov, this medical trial is not looking for participants at present; the first posting was dated March 1st 2006 and its last update was recorded November 22nd 2021. That said, there are 2602 other trials that are currently enrolling patients."

Answered by AI
~11 spots leftby Mar 2025